Healthcare

Trends, opportunity and forecast in throat lozenges market to 2030 by type (hard candy lozenges, soft lozenges, and compressed lozenges), flavor (menthol, honey & ginger, orange, lemon, and others), throat problem (sore throat and cough), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in atopic dermatitis market to 2030 by drug class (PDE-4 inhibitor, corticosteroids, biologics, calcineurin inhibitors, and others), mode of administration (topical, injectable, and oral), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in parenteral nutrition market to 2030 by stage type (adult and pediatrics), indication (Alzheimer's, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, and others), nutrient type (carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in precision medicine market to 2030 by type (inhibitor drugs, monoclonal antibodies, cell & gene therapy, antiviral & anti-retroviral drugs, and others), indication (oncology, rare diseases, infectious diseases, hematological disorders, and others), end use (hospitals & clinics and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in mice model market to 2030 by type (model type and service), therapeutic area (oncology, neurology, metabolic diseases, immunology, cardiovascular diseases, and other), end use (pharmaceutical & biotechnology companies, academic & research institutes, and CROs & CDMOs), application (drug discovery & development, research application, personalized medicine, and), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in genital herpes treatment market to 2030 by drug type (acyclovir, valacyclovir, famciclovir, and other), virus type (HSV-2 and HSV-1), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), route of administration (oral, topical, and injection), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in anti-CD20 monoclonal antibody market to 2030 by product (oncology, neurology, and immunology), type (first generation, second generation, and third generation), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in botulism illness market to 2030 by toxin type (botulinum type A and botulinum type B), treatment type (antitoxins, meticulous airway management, cathartics, foley catheter, and others), drug distribution channel (retail pharmacy and online stores), end use (hospitals & clinics and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in men health supplement market to 2030 by type (sports supplements, probiotic supplements, anti-aging supplements, hair growth supplements, weight management supplements, immune health supplements, and others), age group (20-30, 31-45, 46-60, and above 60), formulation (tablets, capsules, liquids, powders, gummies, and others), distribution channel (online and offline), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in iloprost market to 2030 by product type (capsule and tablet), route of administration (oral, parenteral, and intravenous), application (epilepsy, neuropathic pain, and restless legs syndrome), end use (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in transdermal skin patch market to 2030 by type (single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, and others), application (pain relief, smoking reduction and cessation aid, overactive bladder, hormonal therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in vitiligo treatment market to 2030 by drug class type (corticosteroids, calcineurin inhibitor, and others), type (segmental and non segmental), distribution channel (drug stores & retail pharmacies, online providers, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pseudomonas aeruginosa treatment market to 2030 by medication (monotherapy and combination therapy), drug class (aminoglycoside, cephalosporin, carbapenem, monobactam, and others), route of administration (nasal, oral, and intravenous), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in bronchodilator market to 2030 by indication (asthma, chronic obstructive pulmonary disease, and others), route of administration (oral, injection, and inhaler), drug type (sympathomimetics, anticholinergics, phosphodiesterase inhibitor, combination drugs, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in antiemetic market to 2030 by drug type (antihistamines, serotonin receptor antagonists, dopamine receptor antagonists, neurokinin receptor antagonists, anticholinergics, and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), aplication (chemotherapy, post operative surgery, pregnancy & gatroenteritis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in graft versus host disease treatment market to 2030 by product (corticosteroids, monoclonal antibodies, tyrosine kinase inhibitors, and others), disease type (acute graft-versus-host disease and chronic graft-versus-host disease), end use (hospital pharmacies, online pharmacies, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in tyrosine kinase inhibitor market to 2030 by type (BCR-ABL tyrosine kinase inhibitor, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors, BRAF kinase inhibitors, ROS1 inhibitors, and others), application (chronic myeloid leukemia, lung cancer, breast cancer, renal cell cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in transarterial chemoembolization market to 2030 by product type (chemotherapeutic agents, radio therapeutic agents, and drug-eluting particles), procedure type (conventional TACE and DEB-TACE), indication (unresectable HCC and early-stage HCC), end use (hospitals, clinics, cancer research centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pheochromocytoma market to 2030 by treatment type (alpha blocker, beta blocker, and others), route of administration (oral, parenteral, and others), distribution channel (online channel and offline channel), end use (hospital pharmacy, retail pharmacy, online pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pain patch market to 2030 by type (opioid and non-opioid), route of administration (metered dose and microneedle patches), therapeutic use (pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression), distribution channel (online pharmacies, retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in cancer immunotherapy market to 2030 by technology type (monoclonal antibodies, cytokines & immunomodulators, and others), application (lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and others), end use (hospitals, cancer research centers, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in preclinical asset market to 2030 by service type (bioanalysis & DMPK, toxicology testing, compound management, safety pharmacology, and others), model type (patient derived organoid model and patient derived xenograft model), end use (biopharmaceutical companies, government institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in biopharmaceuticals exicipents market to 2030 by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in cheminformatics market to 2030 by application (chemical analysis, drug discovery, drug validation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in glucagon-like peptide 1 agonists market to 2030 by drug type (exenatide, liraglutide, lixisenatide, and dulaglutide), brand (byetta, bydureon, victoza, trulicity, and lyxumia), route of administration (oral, parenteral, and others), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pharmacogenomics technology market to 2030 by technology (PCR, in-situ hybridization, immunohistochemistry, sequencing, and others), therapeutic area (oncology, neurological disorders, cardiovascular disease, immunological disorders, infectious diseases, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in oral doxycyclin hyclate market to 2030 by type (tablet, capsule, and oral suspension), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), application (intestinal infection, respiratory tract infection, urinary tract infection, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pharmaceutical quality control market to 2030 by product (consumables, instruments, and services), analysis type (sterility testing, bioburden testing, endotoxin testing, stability testing, extractable & leachable testing, raw material testing, and others), products tested (vaccines, plasma product, and drugs), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in metabotropic glutamate receptor market to 2030 by product type (mGlur2, mGlur4, and mGlur5), application (attention deficit hyperactivity disorder, alzheimer's disease, and chronic obstructive pulmonary disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in anticoagulation market to 2030 by drug class (novel oral anticoagulants, heparin and low molecular weight heparin, vitamin K antagonist, and others), route of administration (oral and injectable), application (atrial fibrillation/myocardial infarction, deep vein thrombosis, pulmonary embolism, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in iron deficiency anemia therapy market to 2030 by therapy type (oral iron therapy, parenteral iron therapy, and red blood cell transfusion), end use (hospitals, clinics, and home healthcare), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in intestinal pseudo obstruction treatment market to 2030 by condition (acute and chronic), diagnosis (physical examination, biopsy, blood test, gastric emptying tests, and imaging tests), treatment (medication, surgery, and diet), end use (hospitals & clinics, and ambulatory care centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Trends, opportunity and forecast in myocarditis disease market to 2030 by type (acute myocarditis, chronic myocarditis, and lymphocytic myocarditis), treatment (medication, surgery, and others), diagnosis (blood tests, imaging tests, cardiac catheterization, heart muscle biopsy, and others), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in anti-tuberculosis therapeutics market to 2030 by type (active TB, latent LB, and others), drug classes (isoniazid, rifampin, ethambutol, pyrazinamide, fluoroquinolones, bedaquiline, amynoglycosides, thioamides, cyclic peptides, and others), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in acute ischemic stroke diagnosis market to 2030 by diagnostic type (computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).